Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

Hamamatsu to Distribute Energetiq's LDLStm Products


WOBURN, Mass., Sept. 24, 2018 /PRNewswire-PRWeb/ -- Energetiq Technology, a world leader in high brightness light sources for advanced technology applications, is pleased to announce that starting on October 1, 2018 Hamamatsu will distribute the company's Laser-Driven Light Sources around the globe. Hamamatsu acquired Energetiq in October 2017.

"We have been working steadfastly since our acquisition to integrate with Hamamatsu and familiarize their many sales and marketing engineers worldwide with our technology", said Debbie Gustafson, CEO of Energetiq Technology. "We are proud of the reputation of the Energetiq brand and look forward to working with the Hamamatsu sales team to extend our reach to new customers and new markets."

"We believe Energetiq's Laser-Driven Light Sources add exciting new capabilities to our outstanding portfolio of light source products which now cover from x-ray to infrared," said Naofumi Toriyama, Hamamatsu Board Member and Chairman, Energetiq Board. "Following extensive training of the Hamamatsu sales, marketing and applications team, our staff is ready to support both existing Energetiq customers and to introduce Energetiq's products to Hamamatsu's customers."

This increased global presence in each region supported by Hamamatsu will enable enhanced customer support. The manufacturing and service processes will continue to be operated at Energetiq's headquarters in Woburn, MA, USA.

Sales of Energetiq's Electrodeless Z-Pinchtm Extreme UV sources will continue to be handled by Energetiq.

To view a complete list of whom you should contact for local distribution, please visit http://www.energetiq.com/contactus.

About Energetiq Technology, Inc.
Energetiq Technology, Inc. is a wholly-owned subsidiary of Hamamatsu Photonics. Energetiq combines its deep understanding of the plasma physics needed for high-brightness light generation with its long experience in building rugged industrial & scientific products. The result is that users can expect the highest levels of performance combined with the highest reliability. For more information about Energetiq, please visit http://www.energetiq.com.

About Hamamatsu
Hamamatsu Photonics enables the advancement of photonics through extensive research and skilled manufacturing. Our state-of-the-art products perform a vital role in scientific, industrial, and commercial applications throughout the world. This selection of products includes optical sensors, photodiodes, silicon photomultipliers, photomultiplier tubes, infrared detectors, and systems requiring these components. By applying our products to various new technologies and devices that harness the power of light, Hamamatsu continues to focus on promoting a more comfortable and prosperous society. For more information about Hamamatsu Photonics, visit http://www.hamamatsu.com.

 

SOURCE Energetiq Technology, Inc.


These press releases may also interest you

at 06:00
Biohaven Ltd. , a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology, today announced the pricing of its...

at 06:00
According to a Léger survey conducted for Transplant Québec, more than three in four people favour the adoption, by Québec, of specific and comprehensive legislation governing organ donation and transplantation. At a time when the National Assembly...

at 05:30
Children's Minnesota is thrilled to announce the 32nd annual Star Gala raised $2.3 million to benefit the nonprofit pediatric health system's neuroscience program. Star Gala is regarded as one of the biggest nights of the year for the Twin Cities...

at 04:04
The European Wellness Biomedical Group (EWBG), in collaboration with the European Wellness Academy (EWA), the Baden Research Lab, and Heidelberg University, has announced substantial advances in Down Syndrome research, revealing new neuroanatomical...

at 03:30
Proprietary E3 ligase platform to enable protein stabilisation "at source", thereby restoring the body's sophisticated natural disease suppression processes Platform scales the assessment of E3 ligase targets while addressing the historic challenges...

at 03:00
Todd Britten, DMD, a board-certified periodontist and dental implant specialist in...



News published on and distributed by: